Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07320690
What this trial is testing

De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 356
Testing effectiveness (Phase 2)Study completedNCT03795610
What this trial is testing

IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead and Neck Carcinoma+5 more
Assuntina G. Sacco, MD 16
Testing effectiveness (Phase 2)Study completedNCT00213486
What this trial is testing

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Who this might be right for
Esophageal Neoplasms
University Hospital, Rouen 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05966194
What this trial is testing

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Oral Mucositis
EpicentRx, Inc. 216
Testing effectiveness (Phase 2)Study completedNCT00051480
What this trial is testing

Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer

Who this might be right for
Esophageal Cancer
GenVec
Testing effectiveness (Phase 2)Study completedNCT00095927
What this trial is testing

Randomized Amifostine For SCCHN

Who this might be right for
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Dana-Farber Cancer Institute 58
Large-scale testing (Phase 3)Looking for participantsNCT05357846
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Who this might be right for
Squamous Cell Esophageal CarcinomaEsophageal CancerOesophageal Cancer
Sun Yat-sen University 422
Testing effectiveness (Phase 2)Ended earlyNCT01216020
What this trial is testing

Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsLaryngeal NeoplasmsMouth Neoplasms+1 more
Azienda USL 4 Prato 70
Not applicableUnknownNCT03194061
What this trial is testing

Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

Who this might be right for
Radiotherapy; Complications
Barretos Cancer Hospital 20
Not applicableUnknownNCT00304694
What this trial is testing

Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients

Who this might be right for
Nasopharyngeal Cancer
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06970353
What this trial is testing

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University 40
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Ended earlyNCT01794845
What this trial is testing

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Who this might be right for
Squamous Cell CarcinomaHead and Neck CancerRecurrent Disease
University of Miami 5
Testing effectiveness (Phase 2)Study completedNCT00098345
What this trial is testing

Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Genzyme, a Sanofi Company 40
Not applicableLooking for participantsNCT05892354
What this trial is testing

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University 190
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Large-scale testing (Phase 3)Looking for participantsNCT07706985
What this trial is testing

Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 566
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT02128906
What this trial is testing

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Who this might be right for
Squamous Cell Carcinoma
Christopher Wilke 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05433116
What this trial is testing

Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Universität des Saarlandes 50
Next Page